H. Haapasalo

H. Haapasalo, O. Vapalahti, E. Huhtamo, 2006, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Diagnostically important muscle pathology in DNAJB6 mutated LGMD1D

H. Haapasalo, B. Udd, J. Palmio, 2016, Acta neuropathologica communications.

Specific expression profile and prognostic significance of peroxiredoxins in grade II-IV astrocytic brain tumors

H. Haapasalo, Y. Soini, V. Kinnula, 2010, BMC Cancer.

Extraprostatic extension (pT3a) in prostate biopsy is an under-recognized feature indicating high risk disease.

T. Tammela, T. Tolonen, H. Haapasalo, 2018, Annals of diagnostic pathology.

Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2

A. Paetau, G. Meola, G. Bassez, 2003, Neurology.

PTPRD and CNTNAP2 as markers of tumor aggressiveness in oligodendrogliomas

M. Nykter, O. Yli-Harja, K. Pajtler, 2022, Scientific Reports.

Incidence trends of childhood central nervous system tumors in Finland 1990–2017

H. Haapasalo, O. Lohi, J. Raitanen, 2022, BMC Cancer.

Histopathological and clinical findings in leprosy patients with chronic neuropathic pain: a study from Hyderabad, India.

D. Lockwood, H. Haapasalo, M. Haanpää, 2007, Leprosy review.

A quantitative method for the assessment of intraepidermal nerve fibers in small–fiber neuropathy

H. Haapasalo, J. Peltola, B. Udd, 2005, Journal of Neurology.

Brain phenotype of carbonic anhydrase IX-deficient mice

M. Hilvo, J. Pastorek, S. Pastoreková, 2012, Transgenic Research.

Case report A reversible neuronal antibody (anti‐Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease

H. Haapasalo, J. Peltola, A. Hietaharju, 1998 .

Novel myosin heavy chain immunohistochemical double staining developed for the routine diagnostic separation of I, IIA and IIX fibers

H. Haapasalo, B. Udd, O. Raheem, 2010, Acta Neuropathologica.

Accumulation of genetic changes is associated with poor prognosis in grade II astrocytomas.

J. Kononen, J. Isola, H. Haapasalo, 1997, The American journal of pathology.

The enigma of 7q36 linked autosomal dominant limb girdle muscular dystrophy

H. Haapasalo, B. Udd, P. Hackman, 2010, Journal of Neurology, Neurosurgery & Psychiatry.

Expression of leucine-rich repeats and immunoglobulin-like domains (LRIG) proteins in human ependymoma relates to tumor location, WHO grade, and patient age.

A. Bergenheim, R. Henriksson, H. Haapasalo, 2009, Clinical Neuropathology.

Short Communication Increased Expression of Telomerase RNA Component Is Associated with Increased Cell Proliferation in Human Astrocytomas

J. Kononen, H. Haapasalo, H. Helin, 2007 .

Aberrant DNA methylation distorts developmental trajectories in atypical teratoid/rhabdoid tumors

Minna, M. Nykter, J. Kesseli, 2024, Life Science Alliance.

Intraepidermal nerve fibre density in cancer patients receiving adjuvant chemotherapy.

H. Haapasalo, M. Haanpää, T. Saarto, 2011, Anticancer research.

Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis

J. Kononen, K. Syrjäkoski, H. Haapasalo, 1999, The Journal of pathology.

Decreased expression of antioxidant enzymes is associated with aggressive features in ependymomas

H. Haapasalo, Y. Soini, V. Kinnula, 2008, Journal of Neuro-Oncology.

Antioxidant enzymes in oligodendroglial brain tumors: association with proliferation, apoptotic activity and survival

H. Haapasalo, Y. Soini, V. Kinnula, 2006, Journal of Neuro-Oncology.

Chromosome imbalances in familial gliomas detected by comparative genomic hybridization

J. Kononen, H. Haapasalo, P. Sallinen, 2000, Genes, chromosomes & cancer.

Long-Term Prognosis of Haemangioblastoma of the CNS: Impact of von Hippel-Lindau Disease

J. Kere, J. Jääskeläinen, R. Sankila, 1999, Acta Neurochirurgica.

Abundant expression of HIV Nef and Rev proteins in brain astrocytes in vivo is associated with dementia

I. Elovaara, H. Haapasalo, R. Raininko, 1995, AIDS.

Expression of claudins relates to tumour aggressivity, location and recurrence in ependymomas.

H. Haapasalo, Y. Soini, P. Sallinen, 2013, Histology and histopathology.

278 INTRAEPIDERMAL NERVE FIBER DENSITY IN PATIENTS WITH CHEMOTHERAPY‐INDUCED NEUROPATHY: A PROSPECTIVE STUDY

H. Haapasalo, T. Saarto, P. Kellokumpu-Lehtinen, 2007 .

Prognosis of ovarian carcinomas: Prediction by histoquantitative methods

Y. Collan, E. Pesonen, H. Haapasalo, 1989, Histopathology.

Detection of human herpesvirus-6 in adult central nervous system tumors: predominance of early and late viral antigens in glial tumors

M. Santi, T. MacDonald, H. Haapasalo, 2009, Journal of Neuro-Oncology.

A novel low-penetrance locus for familial glioma at 15q23-q26.3.

J. Kere, V. Ollikainen, P. Onkamo, 2002, Cancer research.

Prognostic factors in WHO grade 2 transitional-cell bladder cancer (TCC); a novel two-grade classification system for TCC based on mitotic index

K. Jauhiainen, H. Haapasalo, P. Lipponen, 2005, Journal of Cancer Research and Clinical Oncology.

Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in suerficial bladder cancer

H. Haapasalo, P. Lipponen, S. Nordling, 2004, Urological Research.

Prediction of superficial bladder cancer by nuclear image analysis.

K. Jauhiainen, H. Haapasalo, P. Lipponen, 1992, European journal of cancer.

Prognostication of astrocytoma patient survival by Ki‐67 (MIB‐1), PCNA, and S‐phase fraction using archival paraffin‐embedded samples

T. Visakorpi, J. Isola, H. Haapasalo, 1994, The Journal of pathology.

Prognostic factors in human pancreatic cancer, with special reference to quantitative histology.

H. Haapasalo, S. Marin, P. Lipponen, 1991, Scandinavian journal of gastroenterology.

Volume corrected mitotic index (M/V-INDEX). The standard of mitotic activity in neoplasms.

Y. Collan, E. Pesonen, H. Haapasalo, 1989, Pathology, research and practice.

Independent clinical, histological and quantitative prognostic factors in transitional‐cell bladder tumours, with special reference to mitotic frequency

K. Jauhiainen, H. Haapasalo, P. Lipponen, 1992, International journal of cancer.

Comparison of three quantitation methods for PCNA immunostaining: Applicability and relation to survival in 83 astrocytic neoplasms

J. Isola, H. Haapasalo, H. Helin, 1993, The Journal of pathology.

Grading of superficial bladder cancer by quantitative mitotic frequency analysis.

K. Jauhiainen, H. Haapasalo, P. Lipponen, 1993, The Journal of urology.

Determinants in Human Pancreatic Cancer

H. Haapasalo, P. Lipponen, M. Eskelinen, 1992 .

DNA ploidy, S-phase fraction, and G2 fraction as prognostic determinants in human pancreatic cancer.

H. Haapasalo, S. Marin, P. Lipponen, 1992, Scandinavian journal of gastroenterology.

Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.

Y. Collan, E. Pesonen, H. Haapasalo, 1991, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

Major prognostic factors in ovarian carcinomas

Y. Collan, H. Haapasalo, N. B. Atkin, 1991, International Journal of Gynecologic Cancer.

Consistency of quantitative methods in ovarian tumor histopathology.

Y. Collan, R. Montironi, E. Pesonen, 1990, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas

H. Haapasalo, Y. Soini, M. Valkonen, 2018, BMC Cancer.

Twist predicts poor outcome of patients with astrocytic glioma

M. Nykter, H. Haapasalo, Y. Soini, 2015, Journal of Clinical Pathology.

Neuron navigator 3 alterations in nervous system tumors associate with tumor malignancy grade and prognosis

K. Ovaska, S. Hautaniemi, H. Haapasalo, 2013, Genes, chromosomes & cancer.

KIT overexpression induces proliferation in astrocytes in an imatinib‐responsive manner and associates with proliferation index in gliomas

P. Kovanen, O. Jänne, K. Peltonen, 2008, International journal of cancer.

Cancer incidence in families with multiple glioma patients

J. Isola, R. Sankila, P. Laippala, 2002, International journal of cancer.

CD109-GP130 interaction drives glioblastoma stem cell plasticity and chemoresistance through STAT3 activity

M. Nykter, H. Haapasalo, P. Laakkonen, 2021, JCI insight.

Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma

M. Nykter, I. Shmulevich, G. Fuller, 2014, Oncogene.

Strong FGFR3 staining is a marker for FGFR3 fusions in diffuse gliomas

M. Nykter, P. Ruusuvuori, Wei Zhang, 2017, Neuro-oncology.

Expression of iron-related genes in human brain and brain tumors

B. Bacon, H. Haapasalo, R. Britton, 2009, BMC Neuroscience.

Clinical association analysis of ependymomas and pilocytic astrocytomas reveals elevated FGFR3 and FGFR1 expression in aggressive ependymomas

M. Nykter, Wei Zhang, T. Visakorpi, 2017, BMC Cancer.

Prognostic Value of the Expression of Tumor Suppressor Genes p53, p21, p16 and pRb, and Ki-67 Labelling in High Grade Astrocytomas Treated with Radiotherapy

H. Haapasalo, L. Talve, E. Salminen, 2004, Journal of Neuro-Oncology.

Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.

H. Haapasalo, T. Paavonen, S. Parkkila, 2014, Histology and histopathology.

Identification of differentially expressed genes in human gliomas by DNA microarray and tissue chip techniques.

O. Kallioniemi, J. Kononen, P. Schraml, 2000, Cancer research.

IGFBP2 potentiates nuclear EGFR-STAT3 signaling

Wei Zhang, M. Nykter, G. Fuller, 2015, Oncogene.

The p38-MK2-HuR pathway potentiates EGFRvIII–IL-1β-driven IL-6 secretion in glioblastoma cells

H. Haapasalo, A. Ammit, J. Haapasalo, 2014, Oncogene.

CHEK2 mutations in primary glioblastomas

Johanna Schleutker, J. Schleutker, H. Haapasalo, 2005, Journal of Neuro-Oncology.

Genetic Aberrations in Sporadic and Neurofibromatosis 2 (NF2)-Associated Schwannomas Studied by Comparative Genomic Hybridization (CGH)

J. Jääskeläinen, H. Haapasalo, H. Helin, 2000, Acta Neurochirurgica.

MK2 Inhibition Induces p53-Dependent Senescence in Glioblastoma Cells

H. Haapasalo, A. Recasens, T. Johns, 2020, Cancers.

New immunohistochemical method for improved myotonia and chloride channel mutation diagnostics

S. Schorge, H. Haapasalo, M. Hanna, 2012, Neurology.

PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma.

Juergen Kast, William C Hahn, Kaisa Teittinen, 2009, Cancer research.

Amplification and overexpression of KIT, PDGFRA, and VEGFR2 in medulloblastomas and primitive neuroectodermal tumors

H. Haapasalo, O. Tynninen, M. Korja, 2010, Journal of Neuro-Oncology.

BMC Cancer BioMed Central Research article Carbonic anhydrase IX in oligodendroglial brain tumors

Seppo Parkkila, J. Pastorek, S. Pastoreková, 2008 .

Stem cell protein BMI‐1 is an independent marker for poor prognosis in oligodendroglial tumours

A. Paetau, H. Haapasalo, O. Tynninen, 2008, Neuropathology and applied neurobiology.

Expression of transmembrane carbonic anhydrases IX and XII in ovarian tumours

W. Sly, J. Pastorek, S. Pastoreková, 2006, Histopathology.

Brain phenotype of carbonic anhydrase IX-deficient mice

M. Hilvo, J. Pastorek, S. Pastoreková, 2012, Transgenic Research.

Carbonic anhydrase VII–a potential prognostic marker in gliomas

H. Haapasalo, S. Parkkila, J. Haapasalo, 2011 .

Carbonic anhydrases in meningiomas: association of endothelial carbonic anhydrase II with aggressive tumor features.

J. Pastorek, S. Pastoreková, H. Haapasalo, 2009, Journal of neurosurgery.

High topoisomerase IIα expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas

J. Isola, P. Kauraniemi, R. Parwaresch, 2000, Neuropathology and applied neurobiology.

Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors

R. Henriksson, H. Haapasalo, D. Guo, 2006, Acta Neuropathologica.

Neurological outcome of childhood brain tumor survivors

A. Koivisto, H. Haapasalo, A. Mäkipernaa, 2012, Journal of Neuro-Oncology.

Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age

Sirkka Goebeler, Heini Huhtala, Teemu Luoto, 2009, Annals of neurology.

Cell Cycle Regulators (p21, p53, pRb) in Oligodendrocytic Tumors: a Study by Novel Tumor Microarray Technique

H. Haapasalo, H. Helin, H. Kalimo, 2001, Journal of Neuro-Oncology.

Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain

M. Nykter, L. Reiniger, V. Téglási, 2019, bioRxiv.

Delayed MR imaging changes in acute disseminated encephalomyelitis.

P. Dastidar, H. Haapasalo, J. Honkaniemi, 2001, AJNR. American journal of neuroradiology.

Cytoplasmic LRIG2 expression is associated with poor oligodendroglioma patient survival

R. Henriksson, H. Haapasalo, H. Hedman, 2009, Neuropathology : official journal of the Japanese Society of Neuropathology.

The tumorigenic FGFR 3-TACC 3 gene fusion escapes miR-99 a regulation in glioblastoma

M. Nykter, G. Fuller, Wei Zhang, 2019 .

Proliferation potential and histological features in neurofibromatosis 2-associated and sporadic meningiomas.

M. Samii, J. Jääskeläinen, M. Tatagiba, 1997, Journal of neurosurgery.

Proliferative Potential of Sporadic and Neurofibromatosis 2-Associated Schwannomas as Studied by MIB-1 (Ki-67) and PCNA Labeling

H. Haapasalo, O. Carpén, M. Sainio, 1995, Journal of neuropathology and experimental neurology.

Expression of Antioxidant Enzymes in Astrocytic Brain Tumors

H. Haapasalo, Y. Soini, V. Kinnula, 2003, Brain pathology.

Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression

A. Auvinen, J. Isola, H. Haapasalo, 2006, Journal of Neuro-Oncology.

Mutant (CCTG)n expansion causes abnormal expression of zinc finger protein 9 (ZNF9) in myotonic dystrophy type 2.

H. Haapasalo, R. Krahe, L. Bachinski, 2010, The American journal of pathology.

Differences in aberrant expression and splicing of sarcomeric proteins in the myotonic dystrophies DM1 and DM2

A. Paetau, K. Baggerly, G. Meola, 2010, Acta Neuropathologica.

The tumour-associated carbonic anhydrases CA II, CA IX and CA XII in a group of medulloblastomas and supratentorial primitive neuroectodermal tumours: an association of CA IX with poor prognosis

W. Sly, J. Pastorek, S. Pastoreková, 2010, BMC Cancer.

New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2)

G. Meola, K. Huoponen, H. Haapasalo, 2004, Neuromuscular Disorders.

Low expression of p27 indicates a poor prognosis in patients with high‐grade astrocytomas

H. Haapasalo, E. Salminen, H. Kalimo, 2003, Cancer.

Integrative DNA methylation analysis of pediatric brain tumors reveals tumor type-specific developmental trajectories and epigenetic signatures of malignancy

M. Nykter, O. Yli-Harja, J. Kesseli, 2022, bioRxiv.

Amplification of the epidermal growth factor receptor in astrocytic tumours by chromogenic in situ hybridization: association with clinicopathological features and patient survival

J. Isola, M. Tanner, H. Haapasalo, 2006, Neuropathology and applied neurobiology.

Peroxiredoxins and their expression in ependymomas

H. Haapasalo, Y. Soini, P. Sallinen, 2012, Journal of Clinical Pathology.

Incidence trends of adult malignant brain tumors in Finland, 1990–2016

A. Auvinen, H. Haapasalo, J. Raitanen, 2019, Acta oncologica.

Prostate‐specific membrane antigen expression in the vasculature of primary lung carcinomas associates with faster metastatic dissemination to the brain

M. Nykter, L. Reiniger, V. Téglási, 2019, bioRxiv.

Comparison of different immunohistochemical methods in the assessment of angiogenesis: lack of prognostic value in a group of 77 selected node-negative breast carcinomas.

J. Isola, H. Haapasalo, H. Helin, 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Expression of Carbonic Anhydrase IX in Astrocytic Tumors Predicts Poor Prognosis

M. Hilvo, J. Pastorek, S. Pastoreková, 2006, Clinical Cancer Research.

Upstream Transcription Factor 1 (USF1) Polymorphisms Associate with Alzheimer's Disease‐related Neuropathological Lesions: Tampere Autopsy Study

T. Lehtimäki, H. Haapasalo, T. Luoto, 2012, Brain pathology.

Incidence of brain tumors in Finland

A. Paetau, A. Auvinen, H. Haapasalo, 2002 .

Is the incidence of meningiomas underestimated? A regional survey

A. Auvinen, R. Sankila, H. Haapasalo, 2008, British Journal of Cancer.

Carbonic anhydrase IX Carbonic anhydrase

H. Haapasalo, S. Parkkila, J. Haapasalo, 2018 .

Carbonic Anhydrase IX in Adult and Pediatric Brain Tumors

H. Haapasalo, S. Parkkila, J. Haapasalo, 2013 .

Complement activation in astrocytomas: deposition of C4d and patient outcome

H. Haapasalo, T. Paavonen, P. Helén, 2012, BMC Cancer.

ERBB receptor signaling promotes ependymoma cell proliferation and represents a potential novel therapeutic target for this disease.

T. Curran, D. Ellison, R. Gilbertson, 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

Divergent clinical and neuropathological phenotype in a Gerstmann–Sträussler–Scheinker P102L family

I. Alafuzoff, H. Haapasalo, S. Capellari, 2012, Acta neurologica Scandinavica.

Grading of diffusely infiltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis

H Kalimo, H. Haapasalo, H. Helin, 2000, Neuropathology and applied neurobiology.

Grading of diffusely in®ltrating astrocytomas by quantitative histopathology, cell proliferation and image cytometric DNA analysis Comparison of 133 tumours in the context of the WHO 1979 and WHO 1993 grading schemes

H. Haapasalo, H. Helin, P. Sallinen, 2000 .

Expression of peripheral-type benzodiazepine receptor and diazepam binding inhibitor in human astrocytomas: relationship to cell proliferation.

J. Kononen, H. Alho, H. Haapasalo, 1995, Cancer research.

Ultrarapid Ki-67 immunostaining in frozen section interpretation of gliomas

J. Isola, H. Haapasalo, A. Mennander, 2005, Journal of Clinical Pathology.

Identifying brain tumors by differential mobility spectrometry analysis of diathermy smoke.

Antti Vehkaoja, Niku Oksala, Anton Kontunen, 2020, Journal of neurosurgery.

Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas

H. Haapasalo, T. Paavonen, M. Korja, 2014, BMC Cancer.

Constant pattern of relapse in primary central nervous lymphoma patients treated with high-dose methotrexate combinations. A Finnish retrospective study

Outi Kuittinen, M. Karjalainen‐Lindsberg, E. Jantunen, 2015, Acta oncologica.

Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas.

W. Sly, M. Hilvo, J. Pastorek, 2008, Neuro-oncology.

Carbonic Anhydrase IX Is Highly Expressed in Hereditary Nonpolyposis Colorectal Cancer

Abdul Waheed, Jukka-Pekka Mecklin, Torben F. Ørntoft, 2007, Cancer Epidemiology Biomarkers & Prevention.

A reversible neuronal antibody (anti-Tr) associated paraneoplastic cerebellar degeneration in Hodgkin's disease.

H. Haapasalo, J. Peltola, A. Hietaharju, 1998, Acta neurologica Scandinavica.

PP2A Inhibitor PME-1 Drives Kinase Inhibitor Resistance in Glioma Cells.

J. Westermarck, H. Haapasalo, J. Eriksson, 2016, Cancer research.

CRP gene variation affects early development of Alzheimer's disease-related plaques

M. Perola, H. Haapasalo, Mervi Alanne-Kinnunen, 2011, Journal of Neuroinflammation.

Exogenous sex hormone use and risk of meningioma: a population-based case–control study in Finland

A. Auvinen, J. Isola, H. Haapasalo, 2010, Cancer Causes and Control.

Absence of KLF6 gene mutations in human astrocytic tumors and cell lines

Erwin G. Van Meir, P. Koivisto, H. Haapasalo, 2004, International journal of cancer.

c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.

O. Kallioniemi, J. Isola, H. Haapasalo, 1996, British Journal of Cancer.

Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer. Finnbladder Group.

H. Haapasalo, P. Lipponen, S. Nordling, 1996, Urological research.

The value of mitotic counting in the assessment of prognosis and proliferation in human tumours

Y. Collan, C. Quinn, N. Wright, 1991, The Journal of pathology.

Analysis of p53 Tumor Suppressor Gene in Families with Multiple Glioma Patients

J. Isola, M. Matikainen, K. Syrjäkoski, 2001, Journal of Neuro-Oncology.

Mitosis counting in tumors.

Y. Collan, H. Haapasalo, Y Collan, 1991, Human pathology.

Large Vessel Cerebral Atherosclerosis Is Not in Direct Association with Neuropathological Lesions of Alzheimer’s Disease

T. Erkinjuntti, H. Haapasalo, H. Huhtala, 2009, European Neurology.

CLU, CR1 and PICALM genes associate with Alzheimer's-related senile plaques

H. Haapasalo, T. Luoto, P. Karhunen, 2011, Alzheimer's Research & Therapy.

HES6 gene is selectively overexpressed in glioma and represents an important transcriptional regulator of glioma proliferation

J. Mpindi, O. Kallioniemi, H. Joensuu, 2012, Oncogene.

Immunohistochemical analysis of LRIG proteins in meningiomas: correlation between estrogen receptor status and LRIG expression

H. Haapasalo, U. Andersson, H. Hedman, 2012, Journal of Neuro-Oncology.

Arm-specific multicolor fluorescence in situ hybridization reveals widespread chromosomal instability in glioma cell lines.

J. Isola, H. Haapasalo, H. Helin, 2003, Cancer genetics and cytogenetics.

Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients’ relatives

M. Nykter, H. Haapasalo, J. Pitkäniemi, 2023, Neuro-oncology advances.

PFKM gene defect and glycogen storage disease GSDVII with misleading enzyme histochemistry

A. Paetau, P. Piirilä, H. Haapasalo, 2015, Neurology: Genetics.

Magnetization Transfer Imaging of Lumbar Disc Degeneration: Correlation of Relaxation Parameters With Biochemistry

H. Haapasalo, M. Laato, H. Paajanen, 1994, Spine.

Desmoplastic infantile ganglioglioma: novel aspects in clinical presentation and genetics.

H. Haapasalo, K. Lönnrot, P. Helén, 2007, Surgical neurology.

NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.

M. Nykter, H. Haapasalo, Y. Soini, 2018, Histology and histopathology.

Proliferation potential of human lumbar disc after herniation.

H. Haapasalo, H. Paajanen, J. Kettunen, 1999, Journal of spinal disorders.

Early-onset grade 2-3 diffuse gliomas and schwannomas increase the risk of central nervous system tumors among the patients’ relatives

M. Nykter, H. Haapasalo, J. Pitkäniemi, 2023, Neuro-oncology advances.

A novel frozen brain tissue array technique: immunohistochemical detection of neuronal paraneoplastic autoantibodies

H. Haapasalo, J. Peltola, P. Karhunen, 2004, Neuropathology and applied neurobiology.

PME-1 protects ERK pathway activity from protein phosphatase 2 A-mediated inactivation in human malignant glioma

W. Hahn, J. Westermarck, H. Haapasalo, 2010 .

Histone mRNA in‐situ hybridization in astrocytomas: a comparison with PCNA, MIB‐1 and mitoses in paraffin‐embedded material

H. Haapasalo, P. Sallinen, I. Rantala, 1998, Histopathology.

Desmoplastic infantile ganglioglioma: novel aspects in clinical presentation and genetics.

H. Haapasalo, K. Lönnrot, P. Helén, 2007, Surgical neurology.

Cyclin D1 expression in astrocytomas is associated with cell proliferation activity and patient prognosis

J. Kononen, H. Haapasalo, H. Helin, 1999, The Journal of pathology.

Peroxiredoxins and antioxidant enzymes in pilocytic astrocytomas.

A. Paetau, H. Haapasalo, Y. Soini, 2007, Clinical Neuropathology.

Carbonic anhydrase IX in oligodendroglial brain tumors

J. Pastorek, S. Pastoreková, H. Haapasalo, 2008, BMC Cancer.